Due to its ability to inhibit IL‐1 signalling and the importance of the IL‐1 pathway for the development of the SASP, we investigated the effects of Y‐27632 on presenescent and senescent cells and examined whether Y‐27632 could modulate the expression of commonly expressed SASP factors related to cancer development. The gene discussed is IL1B; the disease is cancer.